$145,550
median · per year, annualized USD
$103,325
median · per year, annualized USD
Principal Scientist, Oral Formulation Sciences
Staff Membrane Formulation Scientist
Associate Principal Scientist, Oral Formulation Sciences
Principal Scientist, Formulation Development (DPDT)
Principal Scientist - Process & Formulation
Senior Scientist, Oral Formulation Sciences (On-site)
Manager/Principal Scientist Research & Development - Polymer Formulation
Senior Formulation Scientist, Sterile & Peptide Product Development
Principal Scientist – Protein Formulation & Biophysical Characterization (High-Concentration Biologics)
Scientist, Process Development (Formulation)
Senior Specialist I, Postmarketing Patient Safety and Pharmacovigilance Operations
Senior Medical Officer-Infectious Diseases & Pharmacovigilance
Pharmacovigilance QA Auditor Specialist
Pharmacovigilance Specialist - US - Remote
Drug Safety Associate - Bilingual - French - 12-Month Contract
| Company | Median | Roles |
|---|---|---|
MSD
|
$166,925 | 4 |
| DE Dexcom | $189,100 | 1 |
Regeneron
|
$169,300 | 1 |
| BP Bora Pharmaceuticals | $163,500 | 1 |
Hims & Hers
|
$160,000 | 1 |
Avalyn Pharma
|
$156,000 | 1 |
Cresilon, Inc.
|
$155,000 | 1 |
PTC Therapeutics
|
$145,550 | 1 |
| Company | Median | Roles |
|---|---|---|
Corcept Therapeutics
|
$140,850 | 1 |
| GU Guidehouse | $113,000 | 1 |
Johnson & Johnson
|
$103,325 | 1 |
| WC Worldwide Clinical Trials | $74,500 | 1 |
Cencora
|
$31,298 | 1 |
The median for Formulation Scientist is $145,550 per year (typically $96,680–$161,750), versus $103,325 for Pharmacovigilance ($74,500–$113,000). That puts Formulation Scientist about 41% ahead at the median.
Both figures are computed live from active listings on JobsRadar and normalized to annualized USD, so Formulation Scientist and Pharmacovigilance are compared on equal terms regardless of the currency each role was originally posted in. Only roles that publish a salary range feed the medians; numbers refresh every few hours as new roles post and older ones close, so this comparison reflects the market right now rather than a fixed survey. Use it as a directional benchmark when weighing one path against the other.